These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8030255)

  • 21. A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.
    Zhang A; Geisler SC; Smith AD; Resnick DA; Li ML; Wang CY; Looney DJ; Wong-Staal F; Arnold E; Arnold GF
    Biol Chem; 1999 Mar; 380(3):365-74. PubMed ID: 10223339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
    Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
    Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage.
    Döbeli H; Andres H; Breyer N; Draeger N; Sizmann D; Zuber MT; Weinert B; Wipf B
    Protein Expr Purif; 1998 Apr; 12(3):404-14. PubMed ID: 9535709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution.
    Lin T; Porta C; Lomonossoff G; Johnson JE
    Fold Des; 1996; 1(3):179-87. PubMed ID: 9079380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules.
    Mikhailov M; Monastyrskaya K; Bakker T; Roy P
    Virology; 1996 Mar; 217(1):323-31. PubMed ID: 8599217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on hybrid comoviruses reveal the importance of three-dimensional structure for processing of the viral coat proteins and show that the specificity of cleavage is greater in trans than in cis.
    Clark AJ; Bertens P; Wellink J; Shanks M; Lomonossoff GP
    Virology; 1999 Oct; 263(1):184-94. PubMed ID: 10544093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
    Tulasiram P; Suryanarayana V
    Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
    Hernández M; Pozo L; Gómez I; Melchor A
    Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis and immunogenic properties of peptides--fragments of the immunodominant regions of the VP1 protein of the Asia-1 type of foot- and-mouth disease virus].
    Petrov VN; Rybakov SS; Petrova ON; Chepurkin AV; Gulenkin VM
    Bioorg Khim; 1998 Dec; 24(12):899-905. PubMed ID: 10079947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses.
    Arnold GF; Resnick DA; Li Y; Zhang A; Smith AD; Geisler SC; Jacobo-Molina A; Lee W; Webster RG; Arnold E
    Virology; 1994 Feb; 198(2):703-8. PubMed ID: 7507283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
    Chang SY; Vithayasai V; Vithayasai P; Essex M; Lee TH
    J Infect Dis; 2000 Aug; 182(2):442-50. PubMed ID: 10915074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cowpea mosaic virus as a vaccine carrier of heterologous antigens.
    Brennan FR; Jones TD; Hamilton WD
    Mol Biotechnol; 2001 Jan; 17(1):15-26. PubMed ID: 11280928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
    Isaguliants MG; Koshida R; Ruden U; Varen B
    Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity.
    Brand D; Lemiale F; Thibault G; Verrier B; Lebigot S; Roingeard P; Buzelay L; Brunet S; Barin F
    Virology; 2000 Jun; 271(2):350-62. PubMed ID: 10860888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.